NanoString Technologies, Inc. (NASDAQ:NSTG) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET

Company Participants

Doug Farrell - Vice President, Investor Relations

Brad Gray - President and Chief Executive Officer

Tom Bailey - Chief Financial Officer

Conference Call Participants

Alex Vukasin - Canaccord Genuity

Dan Brennan - Cowen

Edmund Debler - Morgan Stanley

Dan Arias - Stifel

Operator

Hello and welcome to the NanoString Second Quarter Operating Results. My name is Katie, and I’ll be coordinating your call today. [Operator Instructions]

I’ll now hand over to your host, Doug Farrell, Vice President of Investor Relations to begin. Doug, please go ahead.

Doug Farrell

Thank you very much. On the call with me today is Brad Gray, our President and CEO; as well as Tom Bailey, our CFO. Earlier today, we released our financial results for the second quarter of 2022.

During this call, we may make statements that are forward-looking, including statements about financial and operating projections, the impact of the COVID-19 pandemic and other macroeconomic factors, future growth trends and related factors, expectations regarding current and future instrument orders, prospects for expanding and penetrating our addressable markets, as well as our strategic focus and objectives, and the development status and anticipated success of recently planned product offerings.

Forward-looking statements are subject to risks and uncertainties, including those described in our SEC filings. Our results may differ materially from those projected, and we undertake no obligation to update any forward-looking statements.

Later in the call, Tom will be discussing our financial results and 2022 guidance. We have prepared as a supplement the GAAP financial measures, selected non-GAAP adjusted measures. The calculation of which are described in detail in our press release. Throughout the call, all financial missions will be GAAP unless otherwise noted. You can also find reconciliations of GAAP to non-GAAP measures, as well as the description, limitations, and rationale for using each measure in this afternoons press release.

With [any] [ph] analysts and investors with their models, we posted exhibits under the Financial Information tab of our Investor Relations home page that include a presentation of non-GAAP or adjusted measures and other selected financial data. I'd like to remind everyone that next week we'll be participating in both the Canaccord and UBS Healthcare Conferences. We look forward to having the opportunity to speak with many of you there.

Now, I’ll turn the call over to Brad.